Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marrow Autologous Cells in Muscular Dystrophy
NCT01834066Phase 2Unknown
- Sponsor
- Chaitanya Hospital
- Start
- Sep 2014
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in Duchenne muscular dystrophy (DMD), sponsored by Chaitanya Hospital. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01834066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01834066.